These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2888798)
1. Development of memory-enhancing agents in the treatment of Alzheimer's disease. Abernethy DR J Am Geriatr Soc; 1987 Oct; 35(10):957-8. PubMed ID: 2888798 [No Abstract] [Full Text] [Related]
2. Therapeutic approaches to Alzheimer's disease. An informal survey of promising drug discovery strategies. Schehr RS Biotechnology (N Y); 1994 Feb; 12(2):140-4. PubMed ID: 7765319 [No Abstract] [Full Text] [Related]
8. Pharmacoepidemiology of tacrine in Alzheimer's disease. Begaud B; Haramburu F; Miremont G Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701 [No Abstract] [Full Text] [Related]
9. Tacrine in Alzheimer's disease. Levy R Lancet; 1989 Aug; 2(8658):329. PubMed ID: 2569126 [No Abstract] [Full Text] [Related]
10. Alzheimer's disease: the role of tacrine therapy. Jogerst G Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656 [No Abstract] [Full Text] [Related]
11. Cholinesterase inhibition in the scopolamine model of dementia. Wesnes KA; Simpson PM; White L; Pinker S; Jertz G; Murphy M; Siegfried K Ann N Y Acad Sci; 1991; 640():268-71. PubMed ID: 1776749 [TBL] [Abstract][Full Text] [Related]
12. Design of new drugs for the treatment of Alzheimer's disease based on tacrine structure. de Aquino RA; Modolo LV; Alves RB; de Fatima A Curr Drug Targets; 2013 Mar; 14(3):378-97. PubMed ID: 23176115 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease: a treatment in sight? Lovestone S; Howard R J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):566-7. PubMed ID: 7500092 [No Abstract] [Full Text] [Related]
15. Treating Alzheimer's disease with cholinergic drugs, Part I. Terpstra T; Terpstra T Nurse Pract; 1998 Nov; 23(11):90, 92, 97 passim. PubMed ID: 9834506 [No Abstract] [Full Text] [Related]
16. Advances in the treatment of Alzheimer's disease. Schneider LS Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210 [No Abstract] [Full Text] [Related]
17. Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease. Ebmeier KP; Hunter R; Curran SM; Dougal NJ; Murray CL; Wyper DJ; Patterson J; Hanson MT; Siegfried K; Goodwin GM Psychopharmacology (Berl); 1992; 108(1-2):103-9. PubMed ID: 1410128 [TBL] [Abstract][Full Text] [Related]
18. [Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?]. Drukarch B; Stoof JC Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1833-5. PubMed ID: 3185771 [No Abstract] [Full Text] [Related]
19. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia. Trzepacz PT; Ho V; Mallavarapu H Psychosomatics; 1996; 37(3):299-301. PubMed ID: 8849507 [No Abstract] [Full Text] [Related]
20. [Clinical study of patients with Alzheimer's disease under treatment with tacrine]. García-López MT; Guardado-Santervás P Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762 [No Abstract] [Full Text] [Related] [Next] [New Search]